Literature DB >> 10642079

Nutritional and metabolic aspects of pancreatic cancer.

A M Cooperman1, J Chivati, R S Chamberlain.   

Abstract

Most patients with pancreatic cancer suffer from a variety of severe metabolic and nutritional disturbances. Despite this fact, the role of perioperative nutritional support for these patients remains controversial. This review highlights the results of randomized prospective clinical trials, and meta-analyses that have addressed this issue. The 'current opinion' put forth in this discussion is based on these reviews, and on personal observations in treating more than 500 patients.

Entities:  

Mesh：

Year:  2000        PMID： 10642079     DOI： 10.1097/00075197-200001000-00004

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN： 1363-1950            Impact factor:   4.294


  3 in total

1.  A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital.

Authors:  Deepta Churm; Inga M Andrew; Keith Holden; Anthony J Hildreth; Colette Hawkins
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

2.  Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.

Authors:  C M M Prado; T Bekaii-Saab; L A Doyle; S Shrestha; S Ghosh; V E Baracos; M B Sawyer
Journal:  Br J Cancer       Date:  2012-04-17       Impact factor: 7.640

Review 3.  Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection.

Authors:  Taylor M Gilliland; Nicole Villafane-Ferriol; Kevin P Shah; Rohan M Shah; Hop S Tran Cao; Nader N Massarweh; Eric J Silberfein; Eugene A Choi; Cary Hsu; Amy L McElhany; Omar Barakat; William Fisher; George Van Buren
Journal:  Nutrients       Date:  2017-03-07       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.